INFICON (IFCN) Q3 2025 earnings summary

Executive summary

• Book-to-bill ratio remained above 1 for the third consecutive quarter, with substantial year-over-year order growth across most end markets and regions, except for Europe and China.

• Q3 sales were $163.9 million, down 4.9% year-over-year, impacted by tough comparisons, trade-related disruptions, and seasonality.

• Operating margin was 14%, affected by trade disputes, capacity duplication, negative FX effects, and tariffs.

• Production reconfiguration was completed globally, positioning the company for future scenarios and reducing exposure to trade barriers.

• Continued investment in R&D (8% of sales) and selective CapEx ($20–25 million) support innovation and market expansion.

Financial highlights

• Q3 sales: $163.9 million, down 4.9% year-over-year and 2.1% sequentially; nine-month sales flat at $489.6 million.

• Gross margin: 43%, down 4.4 percentage points year-over-year, stable sequentially.

• Operating income: $22.9 million (14% of sales), down from 20.3% last year.

• Net income: $17.3 million (10.6% of sales), impacted by lower operating income and higher tax rate (24.7%).

• Operating cash flow: $26.7 million; net cash: $60.5 million, up $9 million year-over-year.

• Equity ratio: 69%, up 4 percentage points year-over-year.

Outlook and guidance

• Full-year 2025 guidance narrowed to $660–680 million in sales and 16–17% operating income margin.

• Path to return to 20%+ operating margin remains a strategic goal, with current margin pressure seen as temporary.

• Visibility remains lower than usual due to market volatility, but order backlog and scenario planning support confidence in guidance.

• Outlook assumes no further significant slowdowns or major unforeseen impacts from trade tensions.